British Association for Psychopharmacology consensus guidance on the use of psychotropic medication preconception, in pregnancy and postpartum 2017.

• 影响指数: 4.562
• 发表时间: 05 2017
• 来源期刊: J Psychopharmacol
• DOI: 10.1177/0269881117699361
• PMID: 28440103
• 文章类型: Journal Article
• 中科院分区: Q2
• 方向: 医学
• 作者列表: McAllister-Williams RH,Baldwin DS,Cantwell R,Easter A,Gilvarry E,Glover V,Green L,Gregoire A,Howard LM,Jones I,Khalifeh H,Lingford-Hughes A,McDonald E,Micali N,Pariante CM,Peters L,Roberts A,Smith NC,Taylor D,Wieck A,Yates LM,Young AH,

关键词: Antidepressants; antipsychotics; anxiolytics; birth defects; breastfeeding; child development; conception; fertility; hypnotics; mood stabilisers; neonatal problems; postpartum; pregnancy; pregnancy outcome; psychiatric illness; psychotropics; teratogenicity

Mesh: Female; Humans; Mental Disorders / drug therapy; Postpartum Period / drug effects; Pregnancy; Psychopharmacology / standards; Psychotropic Drugs / therapeutic use

Abstract

Decisions about the use of psychotropic medication in pregnancy are an ongoing challenge for clinicians and women with mental health problems, owing to the uncertainties around risks of the illness itself to mother and fetus/infant, effectiveness of medications in pregnancy and risks to the fetus/infant from in utero exposure or via breast milk. These consensus guidelines aim to provide pragmatic advice regarding these issues. They are divided into sections on risks of untreated illness in pregnancy; general principles of using drugs in the perinatal period; benefits and harms associated with individual drugs; and recommendations for the management of specific disorders.